|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 254.25 USD | +0.89% |
|
-0.91% | +11.18% |
| 15/07 | RBC Upgrades ResMed to Outperform From Sector Perform, Adjusts Price Target to $294 From $255 | MT |
| 09/07 | Resmed Insider Sold Shares Worth $2,056,076, According to a Recent SEC Filing | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- RMD Stock
- Consensus ResMed, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition